Clinical trial · Observational

Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer

Determination of Utilities for Control of Chemotherapy-Induced Nausea or Vomiting

NCT00416689CI-TRIAL-00022780completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

RATIONALE: Understanding how nausea or vomiting caused by chemotherapy effects a patient's treatment decisions may help doctors plan better cancer treatment and may help patients live more comfortably. PURPOSE: This clinical trial is studying nausea or vomiting in patients who are receiving chemotherapy for breast cancer or lung cancer.

Conditions

Conditions (3)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Breast Cancer	Malignant Breast Neoplasm	CURATED_EXACT	0.92
Lung Cancer	Malignant Lung Neoplasm	CURATED_EXACT	0.92
Nausea and Vomiting	—	UNRESOLVED	—

Interventions

Interventions (2)

Intervention	Type	Mapped drug	Match
assessment of therapy complications	Procedure	—	UNRESOLVED
quality-of-life assessment	Procedure	—	UNRESOLVED

Design

Arms and outcomes

Arms (1)

label
Breast or lung CA pt undergoing chemoTx
interventionNames
1. Procedure: assessment of therapy complications
2. Procedure: quality-of-life assessment

Primary outcomes (0)

[]

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

DISEASE CHARACTERISTICS:

* Diagnosis of breast cancer or lung cancer
* Must be undergoing chemotherapy with each course lasting 3-6 weeks AND meets all of the following criteria:

  * Completed ≥ 1 course with ≥ 1 additional course planned
  * At least 2½ weeks since initiation of the most recent course of chemotherapy

PATIENT CHARACTERISTICS:

* Common Toxicity Criteria performance status 0-2
* Must have command of written and/or spoken English

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Apr 1, 2000
Primary completion: Mar 1, 2003
Completion: Jan 1, 2006
First posted: Dec 28, 2006
Last update posted: Jun 29, 2016
Enrollment: 99 (actual)
Lead sponsor: Alliance for Clinical Trials in Oncology OTHER
Collaborators: National Cancer Institute (NCI)
Keywords: nausea and vomiting, pulmonary carcinoid tumor, recurrent breast cancer, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage IV breast cancer, recurrent non-small cell lung cancer, stage I non-small cell lung cancer, stage II non-small cell lung cancer, stage IIIA non-small cell lung cancer, stage IIIB non-small cell lung cancer, stage IV non-small cell lung cancer, extensive stage small cell lung cancer, limited stage small cell lung cancer, recurrent small cell lung cancer

Data updated 22 days agoSource updated Jun 29, 2016source: clinicaltrials

Locations

Locations by country (0)

No location posted.

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.